Form Type: 4

SEC EDGAR Link
Accession Number:0000899243-21-023429
Date:2021-06-10
Issuer: CLOVIS ONCOLOGY, INC. (CLVS)
Original Submission Date:

Reporting Person:

KLINGENSTEIN PAUL H
C/O CLOVIS ONCOLOGY, INC.
5500 FLATIRON PARKWAY, SUITE 100 BOULDER, CO 80301

Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
Title of SecurityTransaction Date2a. Deemed Execution Date Transaction CodeSharesAcquired or DisposedPrice per share 5. Amount of Securities Beneficially Owned Following Reported Transaction 6. Ownership Form Direct or IndirectNature of Indirect Ownership
Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, convertible securities
Title of Derivative Security Conversion or Exercise Price of Derivative Security Transaction Date Deemed Execution Date Transaction Code Number of Derivative Securities Acquired (A) or Disposed of (D) Date ExercisableExpiration Date Title and Amount of Securities Underlying Derivative Security Price of Derivative Security Number of derivative Securities Beneficially Owned Following Reported Transaction(s) Ownership Form: Direct (D) or Indirect (I) Nature of Indirect Beneficial Ownership
STOCK OPTION (RIGHT TO BUY) 5.97 2021-06-10 deemed execution date A 42,223 (a) 2031-06-10 common stock 42,223 $5.97 42,223 direct
Footnotes
IDfootnote
f1 the options shall vest on the one-year anniversary of the date of grant.

Elevate your investments